Long-term Experience With Intravitreal Anti-VEGF Treatment in Patients With nAMD: Analysis of IRIS® (Intelligent Research in Sight) Registry Database

Related

• 

  End-of-Study Retinal Fluid and Vision Outcomes in the Archway Phase 3 Trial of the Port Delivery System With Ranibizumab in Patients With nAMD

  Aleksandra V. Rachitskaya, MD, FASRS

  Annual Meeting Talks

  2022

• 

  Expert Panel:PDS

  Robert A. Mittra, MD, FASRS

  Dante Joseph Pieramici, MD

  Aleksandra V. Rachitskaya, MD, FASRS

  Margaret A. Chang, MD, MS

  Carl C. Awh, MD, FASRS

  Annual Meeting Talks

  2024

• 

  Prospective Longitudinal Study: Fluid Quantification From Daily Self-imaging With Home OCT in Neovascular Age-Related Macular Degeneration (NV-AMD)

  Jeffrey S. Heier, MD

  Updates from the Field

  2021